Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post 5 Biggest Blockchain ETFs in 2025 June 4, 2025 Next Post S&P 500 Bullish Patterns: Are Higher Highs Ahead? June 4, 2025 Related Posts Lo Herma Hydrogeology Testing & Resource Expansion Drilling September 18, 2025 How to Invest in Vanadium Stocks September 18, 2025 Successful Heavily Supported Placement to Raise $25.1 Million September 18, 2025